<?xml version="1.0" encoding="UTF-8"?>
<ref id="B148">
 <label>148</label>
 <element-citation publication-type="webpage">
  <person-group person-group-type="author">
   <name>
    <surname>Chakraborty</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Sharma</surname>
    <given-names>AR</given-names>
   </name>
   <name>
    <surname>Bhattacharya</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Sharma</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Agoramoorthy</surname>
    <given-names>G</given-names>
   </name>
  </person-group>
  <article-title>COVID-19: consider IL-6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients.</article-title>
  <source>J Med Virol</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1002/jmv.26078</pub-id>
 </element-citation>
</ref>
